
ELV Stock Forecast & Price Target
ELV Analyst Ratings
Bulls say
Elevance Health is well-positioned as a leading provider of healthcare benefits and specialty products, with a strong local market share and a recognized brand. The company's diverse portfolio, including commercial, government, and pharmacy benefit management lines, offers significant growth potential and advantages in the increasingly important shift towards value-based care. Additionally, Elevance's recent strategic investments, disciplined capital deployment, and focus on integration and M&A, position the company for margin expansion and earnings growth in the long term. Overall, Elevance Health's strong fundamentals and potential for continued margin improvement make it an attractive stock to watch for potential investment.
Bears say
Elevance Health is facing downward pressure on its margins due to elevated costs and utilization in its Medicaid business, leading to a projected decline in membership. In addition, the company's shift towards risk-based arrangements and lower margin services in its Carelon business may also impact long-term profitability. There are also risks associated with the ACA market and potential pricing challenges. Overall, these factors contribute to a negative outlook on Elevance Health's stock as it may face challenges in maintaining its current growth trajectory and profitability in the coming years.
This aggregate rating is based on analysts' research of Elevance Health Inc and is not a guaranteed prediction by Public.com or investment advice.
ELV Analyst Forecast & Price Prediction
Start investing in ELV
Order type
Buy in
Order amount
Est. shares
0 shares